American Journal of Emergency Medicine 36 (2018) 1125.e1–1125.e2 Contents lists available at ScienceDirect American Journal of Emergency Medicine journal homepage: www.elsevier.com/locate/ajem Case Report Icatibant for the treatment of orolingual angioedema following the administration of tissue plasminogen activator a b, a c Emily Brown, PharmD , Christina Campana, DO , Jacob Zimmerman, PharmD BCCCP , Steven Brooks, MD Department of Pharmacy, Cleveland Clinic Akron General, 1 Akron General Avenue, Akron, OH 44307, United States Department of Emergency Medicine, Northeast Ohio Medical University, Cleveland Clinic Akron General, 1 Akron General Avenue, Akron, OH 44307, United States Department of Emergency Medicine, Cleveland Clinic Akron General, 1 Akron General Avenue, Akron, OH 44307, United States dyslipidemia presented to the emergency department with sudden Keywords: onset of dysarthria, left facial droop, and left arm weakness. On exam, Icatibant she had left upper and lower extremity weakness, dysarthria, and left Angioedema facial droop. Initial National Institutes of Health Stroke Scale (NIHHS) Tissue plasminogen activator Stroke score was 3. The stroke team was activated and the patient underwent Airway management a non-contrast computed tomography (CT) scan of the brain, which was unremarkable. The patient's symptoms progressed to moderate to se- vere left hand weakness, left sided
The American Journal of Emergency Medicine – Elsevier
Published: Jun 1, 2018
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera